Stock Ratings / Health Care / ELMD / dividends

FOCL (28) CV (43) HSDT (31) VANI (28) ⌘ Pro Terminal →

Electromed Inc. (ELMD) Dividend Safety Gauge & 10-Year DRIP Compounder

$27.04 -2.31% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $26.88

Electromed Inc. (ELMD) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $224.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ELMD Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Electromed Inc. (NYSE: ELMD) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $27.04 (-2.31% 1D, market cap $224.1M). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, ELMD ranks #143 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ELMD compare to FOCL and CV in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ELMD carries a Roarable C (63/100 RQD), trailing P/E of 30.4x, gross margin of 78.1%, and ROIC of 24.1%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $192.1M) and CV (CapsoVision Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $363.3M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ELMD?

▼

Per ELMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001488917), Electromed Inc. generated $64.0M in revenue (+17.0% YoY), $7.5M in net income, and $11.1M in free cash flow against $54.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $26.88 (-0.61%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 17.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+2.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ELMD)Realized 20D OHLCV Swing Band: ±6%

Deterministic 5-Pillar Attribution (63/100 Composite)

🔍 WHY ELMD SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (29% of score)

Altman Z-Score 17.64 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (27% of score)

SEC XBRL FY 2025 (10-K): 17.4% FCF Margin ($11.1M FCF) & 78.1% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$27.68-0.9% Next Q

Q2 (-2Q)

Grade B-$27.44-2.8% Next Q

Q3 (-1Q)

Grade B-$26.66+1.4% Next Q

Current

Grade C$27.04+0.9% Hist 90D α

Trajectory: B (71) → C (63)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ELMD Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, ELMD faces multiple-compression risk if 30.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 75.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.87) or 200D SMA ($31.27) invalidates the momentum regime and cuts Target Base ($27.65) toward Bear Floor ($21.57).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ELMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ELMD Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 63%NO 37%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (11.2% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $28,910

Est. Year-10 Shareholder Yield: $520/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.1K

Yr 1

$12.4K

Yr 2

$13.8K

Yr 3

$15.3K

Yr 4

$17.0K

Yr 5

$18.9K

Yr 6

$21.0K

Yr 7

$23.4K

Yr 8

$26.0K

Yr 9

$28.9K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Cash-Flow & Quality Compounder Desk

Cash-Fortress Compounders: Auditing Free Cash Flow & Yield Safety in ELMD & A-Rated Leaders

✓12-month Bull/Base/Bear fair-value walkthrough on ELMD and its top sector peer
✓Top Roarable A-Rated cash compounders with verified executive & 13F accumulation
✓Includes nightly RQD rating-change & forensic signal email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ELMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.79%🛡️ HOLDING TREND SUPPORT

2026-11-03O $27.68H $27.68L $27.04C $27.04VOL 36.5K

RES: $36.01SUP: $26.29SMA50: $27.87SMA200: $31.27

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ELMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ELMD Butterfly Map → + Track ELMD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

23.5%/yr Implied 5Y Growth

vs. +17.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ELMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ELMD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ELMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ELMD)

Health Care Rank #143 of 1016 ⚔️ FOCL vs ELMD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ELMD vs. FOCL, CV, HSDT, VANI)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Electromed Inc. (ELMD) ranks #143 by composite RQD confidence (63/100, grade C) and #558 by equity capitalization ($224.1M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently leads its immediate peer cohort in composite quantitative strength at 63/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ELMD ACTIVE Electromed Inc.	C	63/100	30.4x	78.1%	24.1%	-2.31%	$224.1M	Benchmark Subject
FOCL EDAP TMS S.A.	E	28/100	—	42.5%	-35.0%	+0.24%	$192.1M	/focl-vs-elmd →
CV CapsoVision Inc.	D-	43/100	—	52.9%	-35.0%	-1.58%	$363.3M	/cv-vs-elmd →
HSDT Solana Company (Class A)	E	31/100	—	96.0%	-35.0%	-7.52%	$135.5M	/hsdt-vs-elmd →
VANI Vivani Medical Inc.	E	28/100	3.9x	—	-35.0%	-4.39%	$98.3M	/vani-vs-elmd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001488917

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Electromed Inc. (ELMD) reported GAAP revenue of $64.0M (+17.0% vs. FY2024 revenue of $54.7M , and +33.1% cumulative change since FY2023) , GAAP net income of $7.5M, operating cash flow of $11.4M, and free cash flow of $11.1M (+26.8% YoY). On the balance sheet, ELMD closed FY2025 with $54.9M in total assets against $0 in total debt (Altman Z-Score: 17.64, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$64.0M	$7.5M	$11.4M	$11.1M	$54.9M	—
FY2024 (FY)	2024-06-30	$54.7M	$5.2M	$9.1M	$8.8M	$52.3M	—
FY2023 (FY)	2023-06-30	$48.1M	$3.2M	$1.3M	$1.3M	—	—

3. ELMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does ELMD compare to FOCL and CV in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for ELMD?

Where is ELMD trading relative to its 50-day, 200-day, and 52-week technical levels?

ELMD last traded at $27.04 (-2.31% on volume of 36,454 shares), positioning the stock -2.98% below its 50-day simple moving average ($27.87) and -13.53% below its 200-day simple moving average ($31.27). Across its 52-week range of $23.01 to $47.40, ELMD sits at the 16.5% percentile with a 14-day RSI of 43.3 (NEUTRAL RANGE) and an implied next-earnings move of ±6.0% ($25.42 to $28.66).

ELMD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does ELMD pay a dividend and is it safe?

Electromed Inc. (ELMD) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: ELMD RQD Cockpit ELMD 12M Forecast ELMD Earnings & Move ELMD Dividends & DRIP ELMD Insiders & 13F ELMD Whale Options ELMD Profit Sankey ELMD News & Why

Sector Peer Dials

Solana Company (Class A)

ELMD Core Snapshot

Market Cap $224.1M

Trailing / Fwd P/E 30.4x / 25.5x

Gross Profit Margin 78.1%

Return on Capital (ROIC) 24.1%

Free Cash Flow Yield 4.85%

12M Base Price Target $27.65

FREE TRADER TOOLS

Own ELMD Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With ELMD → 🏆 Trade ELMD in $100K Prop Arena →

ELMD Wire

Why It Moved →

Direct Company Event Yahoo! Finance Canada • 18h ago

Electromed, Inc. (ELMD) Seasonal Returns Chart - Yahoo Finance

Direct Company Event TradingView • 21h ago

Electromed, Inc. Estimates – AMEX:ELMD

Direct Company Event Yahoo Finance UK • 1d ago

Electromed, Inc. (ELMD) Seasonal returns chart

Direct Company Event Stock Traders Daily • 1d ago

Precision Trading with Electromed Inc. (ELMD) Risk Zones

Peer / Ecosystem Wire Investing.com UK • 1d ago

Electromed at LD Micro Main Event: growth, margins and a CEO exit

ROARABLE RATING BRIEF • RQD 63/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

ELMD — Electromed Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:40:26Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, ELMD scores 65 out of 100 (grade C, verdict "Roarable Hold — Fair / Balanced Risk-Reward"). The five pillars break down as follows:

Fundamental Cash Engine: 17 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 24.1% and an FCF yield of 4.85%. This is the strongest operating signal in the rating and suggests the business generates meaningful returns on the capital it employs.
Whale 13F Flow: 6 / 20. This pillar covers institutional accumulation and options positioning. The low score indicates limited evidence of institutional conviction in the source data.
Insider Conviction: 16 / 20. Per the Roarable RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow. The relatively high score points to insider-side signals that are favorable, though the underlying trade detail is not provided in the source data.
Macro Regime Fit: 8 / 20. Per the Roarable RQD rating, this pillar reflects a Beta of 1.0 and sector sensitivity. The weak score indicates the stock's fit with the current macro regime is limited.
Forensic Balance Sheet: 18 / 20. Per the Roarable RQD rating, this pillar reflects an Altman Z of 17.64, a Piotroski F of 8/9, and Debt/Equity of 0.5. This is the second-strongest pillar and suggests low solvency risk.

For a prospective investor, the picture is mixed. Cash generation and balance-sheet strength are the clearest supports for the rating. Institutional flow and macro fit are the weakest, meaning the stock has less external confirmation and sensitivity to market regime that could cut either way. Valuation metrics (P/E TTM of 30.4, EV/EBITDA of 21.8) sit at levels that, per the market data, already reflect substantial expectations relative to current earnings per share of 0.91. The "Hold" verdict reflects balanced rather than asymmetric risk-reward based on these inputs.

Snapshot

Price	Market Cap	P/E (TTM)	Forward P/E	EV/EBITDA	EPS (TTM)	Dividend Yield	Beta	52-Wk Range	ROIC %
27.68	$229.4M	30.4	25.5	21.8	0.91	0%	1.0	$23.01 - $47.4	24.1%

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$64.0M	$9.7M	$7.5M	N/A	$11.1M	$13.8M	N/A
FY 2024	$54.7M	$6.6M	$5.2M	N/A	$8.8M	$16.2M	N/A
FY 2023	$48.1M	$4.0M	$3.2M	N/A	$1.3M	N/A	N/A

Per the SEC financials, revenue rose from $48.1M (FY 2023) to $64.0M (FY 2025), with net income increasing from $3.2M to $7.5M over the same span. Operating income and free cash flow both expanded across the three reported periods. Per the market data, ROIC is 24.1%, Altman Z-Score is 17.64, and Piotroski F-Score is 8/9 (the latter two per the Roarable RQD rating). Debt/Equity is 0.5 per the Roarable RQD rating; period-level debt figures are not available in source data. Cash declined from $16.2M (FY 2024) to $13.8M (FY 2025) per the SEC financials.

Recent Catalysts & News Wire Analysis

Per the recent news and catalysts feed:

Catalyst (GREEN): An Investing.com UK report references the LD Micro Main Event, with headline themes of growth, margins, and a CEO exit.
Risk Watch (RED): A Stock Traders Daily report on precision risk zones was flagged as a risk-watch item.
Scheduled event (YELLOW): Yahoo Finance reports that Electromed will report Q1 Fiscal 2027 financial results on November 10, 2026.
Market wire items (YELLOW): Yahoo Finance Canada, TradingView (estimates), and Yahoo Finance UK items are tagged as market wire coverage with no specific fundamental content in the summaries.

Per the Butterfly Supply-Chain Graph, supply chain status is NONE, with no butterfly links and no proprietary signals.

Open Questions

What are the specific insider and Congressional transactions behind the 16 / 20 insider conviction score, and over what time window?
What drove the CEO exit referenced in the LD Micro Main Event coverage, and what is the succession plan?
What were the Q1 Fiscal 2027 results expected on November 10, 2026, and how do they compare with prior-period trends?
What is the period-level debt and EPS history, given that these fields are N/A in the financials?
What is the product and customer concentration of revenue, which would determine exposure to reimbursement or procurement shifts?

ELMD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Electromed Inc. (ELMD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ELMD Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 18h ago

Electromed, Inc. (ELMD) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 21h ago

Electromed, Inc. Estimates – AMEX:ELMD

TradingView report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 1d ago

Electromed, Inc. (ELMD) Seasonal returns chart

Yahoo Finance UK report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 1d ago

Precision Trading with Electromed Inc. (ELMD) Risk Zones

Stock Traders Daily report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Investing.com UK • 1d ago

Electromed at LD Micro Main Event: growth, margins and a CEO exit

Investing.com UK report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026

Yahoo Finance report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Traders Daily • 1d ago

The Technical Signals Behind (ELMD) That Institutions Follow

Stock Traders Daily report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Richardson Electronics (RELL) Is a Great Choice for 'Trend' Investors, Here's Why

Yahoo Finance report covering Electromed Inc. (ELMD) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ELMD Bull vs. Bear Conversation Board — What's Your Call at $27.04?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ELMD 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $29.89 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is ELMD (C • RQD 65/100) a Buy at $27.68?

Welcome to the ELMD (Electromed Inc.) Roar Pit. Current RQD Composite is 65/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Biotechnology: Electromedical & Electrotherapeutic Apparatus. Bulls point to capital efficiency (24.1% ROIC), while bears focus on valuation multiple compression (30.4x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $21.59 (-22.0%)

Spot @ $27.68

Pump the brakes on ELMD — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ELMD, but look at what you are paying: 30.4x trailing P/E with 78.1% gross margins. Unless Electromed Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $34.60 (+25.0%)

Spot @ $27.68

ELMD cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ELMD, the market is fixating on short-term headline noise in Biotechnology: Electromedical & Electrotherapeutic Apparatus and ignoring the balance sheet and cash flow trajectory. At $27.68 (52-wk range $23.01 - $47.40), any beat on forward guidance forces shorts and underweight funds to chase.